Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.
Topic:
Atrial Fibrillation (AF)
Sponsored by Roche
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Associate Professor Ziad Hijazi
Uppsala University, Uppsala (Sweden)
4
presentations
0
follower
2 more presentations in this session
Bleeding risk as one of major hurdles in stroke prevention therapy prescription.
Speaker: Professor C. Granger (Durham, US)
How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?
Speaker: Professor P. Kamphuisen (Hilversum, NL)
Access the full session
Biomarker-based approaches for improved atrial fibrillation management
Speakers:
Associate Professor Z. Hijazi, Professor C. Granger, Professor P. Kamphuisen
About the event
ESC 365 is supported by
